Product Name
Glucosylceramide (Soy), Avanti Research™ - A Croda Brand
description
Glucocerebrosides (Soy, 98%)
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (131304P-10mg)
pkg of 1 × 25 mg (131304P-25mg)
pkg of 1 × 5 mg (131304P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
lipid type
sphingolipids
shipped in
dry ice
storage temp.
−20°C
Application
Glucosylceramide (Soy) has been used for the quantitative analysis of plant sphingolipid long-chain bases by gas chromatography-mass spectrometry (GC-MS). It has also been used for enzyme linked immunosorbent assay (ELISA) assay.
Glucosylceramide (Soy) has been used:
- in liposome preparation to test it effect on human α-synuclein aggregation
- as a long chain base source to test alkaline hydrolysis
- to test its immune modulatory effect on natural killer T lymphocytes and dendritic cells
Glucosylceramide (Soy) is suitable:
- for intraperitoneal/oral administration, to treat mice in order to the study the period as an anti-inflammatory model to prevent fibrosis induction
- for the preparation of glycolipids to study its effect on immune mediated colitis
- to coat the wells of microtiter plate and perform enzyme linked immunosorbent assay (ELISA)
Biochem/physiol Actions
The lipid backbones of mammalian GluCer (sphingosine, d18:1(delta4), and ceramide) induce cell death (apoptosis) and inhibit colon carcinogenesis, it is critical to know the structures of GluCer present in plants as a first step toward understanding this potential link between diet and cancer. Previously unexplained fragmentations that were diagnostic for the type of sphingoid base backbone (i.e. by homolytic cleavage of the doubly allylic C-6-C-7 bond to yield a stable distonic allylic radical cation and an allylic radical neutral) were also identified. Hence this method should be useful in the identification of double bonds in sphingolipids, and structure-function relationships between sphingolipids and colon carcinogenesis.†
General description
Glucosylceramide (GluCer) is a major sphingolipid of plant tissue and, thus, abundant in nature and in dietary food sources. This study characterized the molecular species of GluCer from soybean and wheat by low-resolution, high-resolution and tandem mass spectrometry. Soybean GluCer was comprised primarily (>98%) of ceramide with 4,8-sphingadiene (d18:2(delta4,delta8)) and alpha- hydroxypalmitic acid (h16:0); the remainder had the same backbone with h18:0, h20:0, h22:0 and h24:0 fatty acids. Wheat GluCer had three major ceramide, d18:2(delta4,delta8) with h16:0, d18:1(delta8) with h16:0 and d18: 2(delta4,delta8) with h20:0, and smaller amounts of other homologs. These backbones differ from those of mammalian sphingolipids, which often have a delta4-double bond (but rarely a delta8-double bond), and have alpha-hydroxy fatty acids in only some cases.
Packaging
5 mL Amber Glass Screw Cap Vial (131304P-10mg)
5 mL Amber Glass Screw Cap Vial (131304P-25mg)
5 mL Amber Glass Screw Cap Vial (131304P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
No data available
flash_point_c
No data available
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Structure determination of soybean and wheat glucosylceramides by tandem mass spectrometry.
Sullards MC, et al.
Journal of Mass Spectrometry : Jms, 35, 347-353 (2000)
Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis
Qureshi A, et al.
Mycopathologia, 173(5-6), 419-425 (2012)
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes
Margalit M et al.
American Journal of Physiology: Gastrointestinal and Liver Physiology, 289(5), G917-G925 (2005)
??Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune?mediated disorders
E Zigmond, et al.
Gut, 56(1), 82?89-82?89 (2007)
Detection of Antibody against Fungal Glucosylceramide in Immunocompromised Patients: A Potential New Diagnostic Approach for Cryptococcosis
Qureshi A, et al.
Mycopathologia, 173(5-6), 419?425-419?425 (2012)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service